CagriSema is the fixed-ratio combination of cagrilintide + GLP-3 developed by Novo Nordisk as a single weekly injection for obesity
Both are highly purified forms of water, processed to eliminate impurities and microorganisms
Symptoms of a severe allergic reaction include difficulty breathing, swelling of the face or throat, rapid heartbeat, hives, and a sudden drop in blood pressure
Individual responses vary based on age, baseline skin quality, dosing protocol, and consistency of treatment
B12 deficiency can affect individuals of all ages, but most particularly elderly individuals, as older adults are more likely to have decreased stomach acid production, which is necessary for B12 absorption and they easily develop vitamin B12 deficiency